Gene Expression Profiles Identify Biomarkers of Resistance to Decitabine in Myelodysplastic Syndromes

Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease characterized by inefficient hematopoiesis and the potential development of acute leukemia. Among the most notable advances in the treatment of MDS is the hypomethylating agent, decitabine (5-aza-2′deoxycytidine). Although de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seungyoun, Shin, Dong-Yeop, Kim, Dayeon, Oh, Somi, Hong, Junshik, Kim, Inho, Kim, Eunju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700444/
https://www.ncbi.nlm.nih.gov/pubmed/34944006
http://dx.doi.org/10.3390/cells10123494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700444/
https://www.ncbi.nlm.nih.gov/pubmed/34944006
http://dx.doi.org/10.3390/cells10123494

Ejemplares similares